Compare GBLI & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBLI | CGC |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.2M | 404.3M |
| IPO Year | 2010 | 2023 |
| Metric | GBLI | CGC |
|---|---|---|
| Price | $29.20 | $1.07 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.8K | ★ 8.5M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 4.91% | N/A |
| EPS Growth | ★ 70.49 | 36.75 |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $441,187,000.00 | $12,759,000.00 |
| Revenue This Year | $4.18 | $8.04 |
| Revenue Next Year | $6.54 | $4.17 |
| P/E Ratio | $21.95 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.88 | $0.77 |
| 52 Week High | $37.00 | $2.38 |
| Indicator | GBLI | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 58.84 | 42.80 |
| Support Level | $28.54 | $1.01 |
| Resistance Level | $29.72 | $1.25 |
| Average True Range (ATR) | 0.52 | 0.05 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 95.68 | 21.05 |
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance world-wide. The company's two segments are: Penn-America and Non-Core Operations. The Penn-America segment offers specialty property and casualty products designed for its Wholesale Commercial, Specialty Products, InsurTech, and Assumed Reinsurance product offerings. These product lines are offered in the excess and surplus lines marketplace; and Non-Core Operations segment contains lines of business that have been de-emphasized or are no longer being written. The majority of its revenue is from the the Penn-America segment . Geographically, the majority is from California.
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.